• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效液相色谱法测定人血浆和尿液中的他唑巴坦和哌拉西林。

High-performance liquid chromatographic determination of tazobactam and piperacillin in human plasma and urine.

作者信息

Augey V, Grosse P Y, Albert G, Audran M, Bressolle F

机构信息

Laboratoire de Pharmacocinétique, Faculté de Pharmacie, Montpellier, France.

出版信息

J Chromatogr B Biomed Appl. 1996 Jun 28;682(1):125-36. doi: 10.1016/0378-4347(96)00049-7.

DOI:10.1016/0378-4347(96)00049-7
PMID:8832433
Abstract

A high-performance liquid chromatographic (HPLC) method with ultraviolet (UV) absorbance was developed for the analysis of piperacillin-tazobactam (tazocillin), in plasma and urine. The detection was performed at 218 nm for tazobactam and 222 nm for piperacillin. The procedure for assay of these two compounds in plasma and of piperacillin in urine involves the addition of an internal standard (ceftazidime for tazobactam and benzylpenicillin for piperacillin) followed by a treatment of the samples with acetonitrile and chloroform. To quantify tazobactam in urine, diluted samples were analysed using a column-switching technique without internal standard. The HPLC column, LiChrosorb RP-select B, was equilibrated with an eluent mixture composed of acetonitrile-ammonium acetate (pH 5). The proposed technique is reproducible, selective, and reliable. The method has been validated, and stability tests under various conditions have been performed. Linear detector responses were observed for the calibration curve standards in the ranges 5-60 micrograms/ml for tazobactam, and 1-100 micrograms/ml for piperacillin and spans what is currently though to be the clinically relevant range for tazocillin concentrations in body fluids. The limit of quantification was 3 micrograms/ml for tazobactam and 0.5 microgram/ml for piperacillin in plasma and urine. Extraction recoveries from plasma proved to be more than 85%. Precision, expressed as C.V., was in the range 0.4-18%.

摘要

建立了一种采用紫外吸光法的高效液相色谱(HPLC)方法,用于分析血浆和尿液中的哌拉西林 - 他唑巴坦(他唑西林)。他唑巴坦在218 nm处进行检测,哌拉西林在222 nm处进行检测。血浆中这两种化合物以及尿液中哌拉西林的测定程序包括加入内标(他唑巴坦用头孢他啶,哌拉西林用苄青霉素),然后用乙腈和氯仿处理样品。为了定量尿液中的他唑巴坦,使用柱切换技术对稀释后的样品进行分析,无需内标。HPLC柱LiChrosorb RP - select B用由乙腈 - 醋酸铵(pH 5)组成的洗脱液混合物平衡。所提出的技术具有可重复性、选择性和可靠性。该方法已经过验证,并进行了各种条件下的稳定性测试。对于校准曲线标准品,观察到线性检测器响应,他唑巴坦的范围为5 - 60微克/毫升,哌拉西林的范围为1 - 100微克/毫升,涵盖了目前认为的体液中他唑西林浓度的临床相关范围。血浆中他唑巴坦的定量限为3微克/毫升,哌拉西林为0.5微克/毫升。血浆的提取回收率超过85%。以变异系数(C.V.)表示的精密度在0.4 - 18%范围内。

相似文献

1
High-performance liquid chromatographic determination of tazobactam and piperacillin in human plasma and urine.高效液相色谱法测定人血浆和尿液中的他唑巴坦和哌拉西林。
J Chromatogr B Biomed Appl. 1996 Jun 28;682(1):125-36. doi: 10.1016/0378-4347(96)00049-7.
2
High performance liquid chromatographic determination of plasma free and total tazobactam and piperacillin.高效液相色谱法测定血浆中游离和总他唑巴坦及哌拉西林的含量。
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jan 1;877(1-2):86-8. doi: 10.1016/j.jchromb.2008.11.010. Epub 2008 Nov 13.
3
Development and optimization of a reversed-phase high-performance liquid chromatographic method for the determination of piperacillin and tazobactam in tazocin injectable powder.他唑仙注射用粉末中哌拉西林和他唑巴坦含量测定的反相高效液相色谱法的建立与优化
J Pharm Biomed Anal. 2002 Jul 31;29(5):787-93. doi: 10.1016/s0731-7085(02)00129-2.
4
Determination of tazobactam and piperacillin in human plasma, serum, bile and urine by gradient elution reversed-phase high-performance liquid chromatography.采用梯度洗脱反相高效液相色谱法测定人血浆、血清、胆汁和尿液中的他唑巴坦和哌拉西林。
J Chromatogr. 1989 Nov 10;496(1):167-79. doi: 10.1016/s0378-4347(00)82563-3.
5
An improved high-performance liquid chromatographic method with a solid-phase extraction for the determination of piperacillin and tazobactam: application to pharmacokinetic study of different dosage in Chinese healthy volunteers.一种改进的高效液相色谱法结合固相萃取用于哌拉西林和他唑巴坦的测定:在中国健康志愿者中不同剂量的药代动力学研究中的应用
Biomed Chromatogr. 2007 Jul;21(7):680-6. doi: 10.1002/bmc.800.
6
A UHPLC-MS/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy effluent.一种 UHPLC-MS/MS 法,用于同时测定血浆(总浓度和游离浓度)、尿液和肾脏替代治疗流出液中的哌拉西林和他唑巴坦。
J Pharm Biomed Anal. 2018 Jan 30;148:324-333. doi: 10.1016/j.jpba.2017.10.023. Epub 2017 Oct 25.
7
New and rapid fully automated method for determination of tazobactam and piperacillin in fatty tissue and serum by column-switching liquid chromatography.采用柱切换液相色谱法测定脂肪组织和血清中他唑巴坦和哌拉西林的新型快速全自动方法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Aug 5;775(2):127-32. doi: 10.1016/s1570-0232(02)00298-2.
8
A simple and rapid RP-HPLC method for the simultaneous determination of piperacillin and tazobactam in human plasma.一种用于同时测定人血浆中哌拉西林和他唑巴坦的简单快速的反相高效液相色谱法。
J Pharm Biomed Anal. 2016 Nov 30;131:80-86. doi: 10.1016/j.jpba.2016.08.010. Epub 2016 Aug 9.
9
Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC.通过高效液相色谱法测定接受持续静脉-静脉血液滤过治疗的患者血浆和超滤液中哌拉西林和他唑巴坦的含量及稳定性。
Biomed Chromatogr. 2005 Oct;19(8):570-8. doi: 10.1002/bmc.482.
10
High-performance liquid chromatographic determination of tazobactam by precolumn derivatization.柱前衍生化高效液相色谱法测定他唑巴坦
J Chromatogr B Biomed Appl. 1995 Oct 6;672(1):160-4. doi: 10.1016/0378-4347(95)00193-m.

引用本文的文献

1
Preanalytical Stability of 13 Antibiotics in Biological Samples: A Crucial Factor for Therapeutic Drug Monitoring.生物样品中13种抗生素的分析前稳定性:治疗药物监测的关键因素
Antibiotics (Basel). 2024 Jul 20;13(7):675. doi: 10.3390/antibiotics13070675.
2
Therapeutic drug monitoring of piperacillin and tazobactam by RP-HPLC of residual blood specimens.采用反相高效液相色谱法测定残留血样中的哌拉西林和他唑巴坦的治疗药物监测。
Clin Chim Acta. 2018 Jul;482:60-64. doi: 10.1016/j.cca.2018.03.021. Epub 2018 Mar 26.
3
Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).
抗假单胞菌β-内酰胺类药物通过便携式弹性泵(用于囊性纤维化患者的家庭治疗)和电动注射器(重症监护病房)进行潜在给药的比较稳定性研究。
Antimicrob Agents Chemother. 2002 Aug;46(8):2327-32. doi: 10.1128/AAC.46.8.2327-2332.2002.